PubMed:24691501 / 550-776
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T63 | 41-47 | CVCL_E024 | denotes | Gemini |
| T67 | 48-57 | 11253 | denotes | vitamin D |
| T65 | 48-57 | CHEBI:89324 | denotes | vitamin D |
| T66 | 48-57 | D014807 | denotes | vitamin D |
| T68 | 48-57 | D014807 | denotes | vitamin D |
| T69 | 48-57 | CHEBI:27300 | denotes | vitamin D |
| T70 | 84-88 | CVCL_D496 | denotes | R-21 |
| T71 | 91-98 | CHEBI:43176 | denotes | hydroxy |
| T75 | 162-177 | 2418 | denotes | cholecalciferol |
| T72 | 162-177 | CHEBI:28940 | denotes | cholecalciferol |
| T73 | 162-177 | D002762 | denotes | cholecalciferol |
| T74 | 162-177 | D002762 | denotes | cholecalciferol |
| T76 | 179-186 | C552206 | denotes | BXL0124 |
| T77 | 179-186 | C552206 | denotes | BXL0124 |
| T78 | 200-209 | CHEBI:35222 | denotes | inhibitor |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 41-47 | HP_0011091 | denotes | Gemini |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-226 | DRI_Approach | denotes | We have previously reported that a novel Gemini vitamin D analog, 1α,25-dihydroxy-20R-21(3-hydroxy-3-deuteromethyl-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluoro-cholecalciferol (BXL0124) is a potent inhibitor of the growth of |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-226 | DRI_Approach | denotes | We have previously reported that a novel Gemini vitamin D analog, 1α,25-dihydroxy-20R-21(3-hydroxy-3-deuteromethyl-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluoro-cholecalciferol (BXL0124) is a potent inhibitor of the growth of |